Chartwell Investment Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-31,594
Closed -$1.66M 414
2017
Q4
$1.66M Sell
31,594
-20,965
-40% -$1.12M 0.06% 349
2017
Q3
$2.48M Buy
+52,559
New +$2.12M 0.08% 293
2016
Q4
Sell
-188,885
Closed -$3.51M 424
2016
Q3
$3.51M Buy
+188,885
New +$3.33M 0.06% 303

Other funds holding EXAS

Chartwell Investment Partners's EXAS Position: Q1 2018 in Review

Chartwell Investment Partners sold out of Exact Sciences (EXAS) in Q1 2018, closing a stake of 31,594 shares — an estimated $1.66M sold.

Chartwell Investment Partners first reported a position in EXAS in Q3 2016 and held it in 3 quarters. The position peaked at $3.51M in Q3 2016. 319 funds tracked by Wall St. Rank hold EXAS as of Q1 2018.

  • Chartwell Investment Partners reported no remaining Exact Sciences position as of Q1 2018 after selling out during the quarter.
  • Chartwell Investment Partners sold 31,594 Exact Sciences shares in Q1 2018, an estimated $1.66M.
  • Chartwell Investment Partners first reported a position in Exact Sciences in Q3 2016 and held it in 3 quarters.
  • Chartwell Investment Partners's Exact Sciences position peaked at $3.51M in Q3 2016.
  • 319 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2018.

Based on Chartwell Investment Partners's 13F filing for Q1 2018, filed 8 May 2018.